洞察市场格局
解锁药品研发情报

客服电话

400-9696-311

医药数据查询

【ChiCTR2500105487】Motivational interviewing intervention to enhance self-learning and practicing of Tai Chi in patients with advanced lung cancer: A feasibility randomized controlled trial

查看原文

立即下载

基本信息

登记号

ChiCTR2500105487

试验状态

正在进行

药物名称

药物类型

规范名称

首次公示信息日的期

2025-07-04

临床申请受理号

靶点

适应症

Advanced Lung Cancer

试验通俗题目

Motivational interviewing intervention to enhance self-learning and practicing of Tai Chi in patients with advanced lung cancer: A feasibility randomized controlled trial

试验专业题目

Motivational interviewing intervention to enhance self-learning and practicing of Tai Chi in patients with advanced lung cancer: A feasibility randomized controlled trial

申办单位信息

申请人联系人

申请人名称

联系人邮箱

联系人邮编

联系人通讯地址

临床试验信息

试验目的

To examine the feasibility and the potential effectiveness of MI interventions to enhance self-learning and practicing of Tai Chi among patients with advanced lung cancer at 3-month and 6-month follow-ups compared with the control group.

试验分类

试验类型

随机平行对照

试验分期

其它

随机化

An independent statistician will generate the randomization list using computer and keep a secure copy of the randomization code assignments.

盲法

The RAs responsible for assessing the outcome measures and entering the data will be blinded as to group allocation.

试验项目经费来源

Health and Medical Research Fund

试验范围

目标入组人数

实际入组人数

第一例入组时间

2024-12-30

试验终止时间

2026-01-15

是否属于一致性

入选标准

排除标准

1. Suffering from a condition that hinders exercise performance (e.g., active neurological disorder, recent heart attack, or chronic obstructive pulmonary disease); 2. Engaging in regular exercise, defined as at least 150 minutes of moderate-intensity exercise per week; 3. Scored 7 or higher on the contemplation ladder (preparation, action or maintenance stage).；

研究者信息

研究负责人姓名

试验机构

The University of Hong Kong

研究负责人电话

研究负责人邮箱

研究负责人邮编

联系人通讯地址

<END>